2025
Risk of unprovoked seizures after discontinuation of antiseizure medication at discharge following acute symptomatic seizures
Punia V, Byrnes M, Thompson N, Ayub N, Rubinos C, Zafar S, Sivaraju A, investigators F. Risk of unprovoked seizures after discontinuation of antiseizure medication at discharge following acute symptomatic seizures. Epilepsia 2025 PMID: 40387211, DOI: 10.1111/epi.18464.Peer-Reviewed Original ResearchAcute symptomatic seizuresAntiseizure medicationsUnprovoked seizuresRisk of unprovoked seizuresSymptomatic seizuresAssociated with electrographic seizuresMedian Follow-UpRetrospective cohort studyCox proportional hazards modelsCause-specific Cox proportional hazards modelsProportional hazards modelIncidence of unprovoked seizuresASyS patientsConsecutive adultsSingle-centerElectrographic seizuresNo significant differenceCumulative incidenceFollow-upCohort studyPatient populationFunctional outcomesSeizure riskPatientsHospital dischargeManagement and Outcomes in Confirmed or Suspected Acute Symptomatic Seizure: Role of Structured Outpatient Care
Punia V, Byrnes M, Thompson N, Ayub N, Rubinos C, Zafar S, Sivaraju A, Ying Z, Fesler J, Hantus S, investigators P. Management and Outcomes in Confirmed or Suspected Acute Symptomatic Seizure: Role of Structured Outpatient Care. Annals Of Clinical And Translational Neurology 2025, 12: 1225-1239. PMID: 40244869, PMCID: PMC12172096, DOI: 10.1002/acn3.70039.Peer-Reviewed Original ResearchConceptsAcute symptomatic seizuresSymptomatic seizuresUnprovoked seizuresASyS patientsEpileptiform abnormalitiesMedian 14-month follow-upContinuous EEGRetrospective study of adultsCox proportional hazards modelsCause-specific Cox proportional hazards modelsProportional hazards modelRisk of unprovoked seizuresOutpatient EEGAlive patientsStudy of adultsOutpatient careSingle-centerRetrospective studyFollow-upPatientsCumulative incidence functionHazards modelSeizuresPost-discharge managementAbnormalities
2024
Antiseizure Medication Use and Outcomes After Suspected or Confirmed Acute Symptomatic Seizures
Zafar S, Sivaraju A, Rubinos C, Ayub N, Awodutire P, McKee Z, Chandan P, Byrnes M, Bhansali S, Rice H, Smith-Ayala A, Haider M, Tveter E, Erlich-Malona N, Ibanhes F, DeMarco A, Lewis S, Dhakar M, Punia V. Antiseizure Medication Use and Outcomes After Suspected or Confirmed Acute Symptomatic Seizures. JAMA Neurology 2024, 81: 1159-1169. PMID: 39312247, PMCID: PMC11420826, DOI: 10.1001/jamaneurol.2024.3189.Peer-Reviewed Original ResearchAssociated with increased oddsAcute symptomatic seizuresAntiseizure medication treatmentDischarge prescriptionsSymptomatic seizuresAntiseizure medicationsElectrographic seizuresContinuous electroencephalographyOdds of treatmentGlasgow Outcome Scale scoreNeurological intensive care unitOptimal treatment durationMulticenter cohort studyAntiseizure medication useOutcome Scale scorePrescribed antiseizure medicationsAssociated with functional outcomeIntensive care unitAssociated with outcomeMain OutcomesProgressive brain injuryASM treatmentMedication useCohort studyEpileptiform abnormalitiesAntiseizure Medication Withdrawal, Risk of Epilepsy, and Longterm EEG Trends in Acute Symptomatic Seizures or Epileptic EEG Patterns
Sivaraju A, Tao A, Jadav R, Kirunda K, Rampal N, Kim J, Gilmore E, Hirsch L. Antiseizure Medication Withdrawal, Risk of Epilepsy, and Longterm EEG Trends in Acute Symptomatic Seizures or Epileptic EEG Patterns. Neurology Clinical Practice 2024, 14: e200342. PMID: 39185097, PMCID: PMC11341085, DOI: 10.1212/cpj.0000000000200342.Peer-Reviewed Original ResearchImmediate and long‐term management practices of acute symptomatic seizures and epileptiform abnormalities: A cross‐sectional international survey
Punia V, Daruvala S, Dhakar M, Zafar S, Rubinos C, Ayub N, Hirsch L, Sivaraju A, investigators F. Immediate and long‐term management practices of acute symptomatic seizures and epileptiform abnormalities: A cross‐sectional international survey. Epilepsia 2024, 65: 909-919. PMID: 38358383, DOI: 10.1111/epi.17915.Peer-Reviewed Original ResearchAnti-seizure medicationsEpileptiform abnormalitiesAcute symptomatic seizuresAcute brain injuryContinuous EEGSecondary prophylaxisSymptomatic seizuresSporadic epileptiform dischargesLateralized periodic dischargesCross-sectional international surveyOutpatient follow-upAnti-seizure medication useOptimal care pathwayDose escalationBrain injuryDose changesLong-term managementElectrographic seizuresEpileptiform dischargesFollow-upAncillary testsReal-world practiceRecommended durationContinuous electroencephalographyHospital dischargeCharacteristics and Attendance of Patients Eligible for the PASS Clinic: A Transition of Care Model After Acute Symptomatic Seizures.
Byrnes M, Thompson N, Hantus S, Fesler J, Ying Z, Ayub N, Rubinos C, Zafar S, Sivaraju A, Punia V. Characteristics and Attendance of Patients Eligible for the PASS Clinic: A Transition of Care Model After Acute Symptomatic Seizures. Neurology Clinical Practice 2024, 14: e200232. PMID: 38213398, PMCID: PMC10781564, DOI: 10.1212/cpj.0000000000200232.Peer-Reviewed Original ResearchAntiseizure medicationsClinic attendanceASY patientsClinic modelCare modelCause-specific Cox proportional hazards modelsMedicare/Medicaid insuranceCox proportional hazards modelAcute symptomatic seizuresClinic attendance ratesClinic visit attendanceEarly postdischarge mortalityProgressive brain injuryRetrospective cohort studyAttendance of patientsRoutine clinical careProportional hazards modelDischarge planning processASM discontinuationAutoimmune encephalitisPostdischarge mortalitySymptomatic seizuresVisit attendanceSeizure clinicCohort study
2023
Do acute EEG findings add to clinical features in predicting outcomes after status epilepticus and acute symptomatic seizures?
Sivaraju A, Hirsch L. Do acute EEG findings add to clinical features in predicting outcomes after status epilepticus and acute symptomatic seizures? Epilepsy & Behavior 2023, 141: 109134. PMID: 36848748, DOI: 10.1016/j.yebeh.2023.109134.Peer-Reviewed Original ResearchConceptsAcute symptomatic seizuresAnti-seizure medicationsStatus epilepticusEEG findingsSymptomatic seizuresSeizure clinicFunctional outcomeClinical careLong-term clinical careLife-threatening medical emergencyAcute EEG findingsLondon-Innsbruck ColloquiumSubsequent unprovoked seizuresPoor functional outcomeContinuous EEG monitoringAcute seizuresNonconvulsive seizuresClinical featuresPediatric populationUnprovoked seizuresEpileptiform abnormalitiesEpileptic patternsSpecialty clinicTreatment strategiesPrognostic accuracyImpact of acute symptomatic seizures and their management on patient-reported outcomes after stroke
Punia V, Li Y, Lapin B, Chandan P, Newey C, Hantus S, Dhakar M, Rubinos C, Zafar S, Sivaraju A, Katzan I, investigators F. Impact of acute symptomatic seizures and their management on patient-reported outcomes after stroke. Epilepsy & Behavior 2023, 140: 109115. PMID: 36804847, DOI: 10.1016/j.yebeh.2023.109115.Peer-Reviewed Original ResearchConceptsPatient-reported outcome measuresAnti-seizure medicationsAcute symptomatic seizuresOutcome measuresSymptomatic seizuresHospital dischargeASM useExact testFirst patient-reported outcome measureRetrospective cohort studyPatient-reported outcomesStandard of careContinuous EEG monitoringFisher's exact testWilcoxon rank sum testChi-square testRank sum testPROM completionStroke clinicCohort studyRecent strokeStroke patientsNeuro-QoLPhysical functionPatients
2022
Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody‐positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody‐associated disease
Li E, Zheng Y, Cai M, Lai Q, Fang G, Du B, Shen C, Zhang Y, Wu L, Ding M. Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody‐positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody‐associated disease. Epilepsia 2022, 63: 2173-2191. PMID: 35652436, DOI: 10.1111/epi.17315.Peer-Reviewed Original ResearchConceptsMyelin oligodendrocyte glycoprotein antibody-associated diseaseAquaporin-4 antibody-positive neuromyelitis optica spectrum disorderNeuromyelitis optica spectrum disorderAntibody-associated diseaseMultiple sclerosisCentral nervous system inflammatory demyelinating diseaseAutoimmune-associated epilepsyCerebral cortical encephalitisConcomitant systemic infectionPresence of status epilepticusAcute disseminated encephalomyelitisInflammatory demyelinating diseaseSecondary to inflammationAcute symptomatic seizuresDrug-drug interactionsAQP4-NMOSDCortical encephalitisMultiple relapsesDisseminated encephalomyelitisImpact of treatmentStatus epilepticusDisease activitySymptomatic seizuresAntiseizure medicationsInflammatory mechanismsAcute symptomatic seizures: an educational, evidence‐based review
Mauritz M, Hirsch LJ, Camfield P, Chin R, Nardone R, Lattanzi S, Trinka E. Acute symptomatic seizures: an educational, evidence‐based review. Epileptic Disorders 2022, 24: 26-49. PMID: 34789447, DOI: 10.1684/epd.2021.1376.Peer-Reviewed Original Research
2020
Seizure occurrence in myelin oligodendrocyte glycoprotein antibody-associated disease: A systematic review and meta-analysis
Shen C, Zheng Y, Cai M, Yang F, Fang W, Zhang Y, Ding M. Seizure occurrence in myelin oligodendrocyte glycoprotein antibody-associated disease: A systematic review and meta-analysis. Multiple Sclerosis And Related Disorders 2020, 42: 102057. PMID: 32222694, DOI: 10.1016/j.msard.2020.102057.Peer-Reviewed Original ResearchConceptsMOG-Ab-associated diseaseAcute symptomatic seizuresSymptomatic seizuresMeta-analysisMyelin oligodendrocyte glycoprotein antibody-associated diseaseSystematic reviewMyelin oligodendrocyte glycoprotein antibody (MOG-Ab)-associated diseaseAntibody-associated diseaseSeizure occurrenceEpileptic seizuresProbability of seizure occurrenceProportion of childrenRandom-effects modelOccurrence of epileptic seizuresOccurrence of seizuresOccurrence of acute symptomatic seizuresClinical presentationMeta-analysis objectivePooled resultsInclusion criteriaPooled probabilitySeizuresDiseaseEffects modelPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply